Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2012
11/29/2012US20120302632 Dietary control of arachidonic acid metabolism
11/29/2012US20120302629 Biomarkers for gossypol chemotherapy and methods of treating disease
11/29/2012US20120302620 Novel pyrone-indole derivatives and process for their preparation
11/29/2012US20120302618 Use of benzydamine in the treatment of p40-dependent diseases
11/29/2012US20120302617 Phenyl and Benzodioxinyl Substituted Indazoles Derivatives
11/29/2012US20120302609 Pyrazolines for the Modulation of PKM2
11/29/2012US20120302608 Novel Imidazole Derivatives Useful for the Treatment of Arthritis
11/29/2012US20120302607 C4-substituted alpha-keto oxazoles
11/29/2012US20120302602 Vanilloid Receptor Ligand Compounds, Pharmaceutical Compositions Containing Them, a Method of Producing Them and the Use Thereof to Treat Pain and Various Other Conditions
11/29/2012US20120302597 Novel p2x7r antagonists and their use
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302583 New Compounds I
11/29/2012US20120302578 Aminooxazole Inhibitors of Cyclin Dependent Kinases
11/29/2012US20120302574 Methods of Preventing and Reducing the Severity of Stress-Associated Conditions
11/29/2012US20120302569 Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012US20120302561 Compounds, Formulations, and Methods of Protein Kinase C Inhibition
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/29/2012US20120302551 Thiolactams and uses thereof
11/29/2012US20120302543 Compounds for the Treatment of Neurological Disorders
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302537 Treatment methods using pharmaceutical solid state forms
11/29/2012US20120302533 Derivatives of pyrimido [6,1-a] isoquinolin-4-one
11/29/2012US20120302531 beta-2-Adrenoreceptor Agonists
11/29/2012US20120302528 Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates
11/29/2012US20120302518 Polymorphic Form Of N-(S)-(3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)-6-Methoxyphenyl)-1-(2,3-Dihydroxypropyl)Cyclopropane-1-Sulfonamide And Uses Thereof
11/29/2012US20120302505 Cyclodextrin-based polymers for therapeutic delivery
11/29/2012US20120302498 Insulin like peptides
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120301552 CaSR Antagonist
11/29/2012US20120301527 Hair follicle targeting compositions
11/29/2012US20120301514 Development of bioactive electrospun coatings for biomedical applications
11/29/2012US20120301511 Topical formulation comprising a corticosteroid as active ingredient
11/29/2012US20120301510 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/29/2012US20120301495 Antigen peptide and use thereof
11/29/2012US20120301488 Anti-cd40 antibodies and methods of use
11/29/2012US20120301487 Method for in-vivo binding of chromatin fragments
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
11/29/2012US20120301482 Methods and compositions for treatment of lung injury
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301469 amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
11/29/2012US20120301462 Compounds
11/29/2012US20120301460 Subcutaneously administered anti-il-6 receptor antibody
11/29/2012US20120301451 Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
11/29/2012US20120301435 Probiotic bifidobacterial composition in accordance with secretor blood group status
11/29/2012US20120301434 Antibacterial polypeptides and use thereof
11/29/2012US20120301432 novel boswellia low polar gum resin extract and its synergistic compositions
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120301403 Polyethylene glycolated superoxide dismutase mimetics
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012CA2837184A1 Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
11/29/2012CA2837096A1 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
11/29/2012CA2835755A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/29/2012CA2834589A1 Method for preparing fc-containing polypeptides having improved properties
11/29/2012CA2834397A1 Use of fermented wheat germ in the treatment of inflammatory bowel disease
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2527339A1 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
11/28/2012EP2527335A1 Triazole compounds as anti-inflammatory agents
11/28/2012EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent
11/28/2012EP2527319A1 Crystalline forms of pregabalin and co-formers in the treatment of pain
11/28/2012EP2526941A1 Anti-inflammatory Modalities
11/28/2012EP2526100A1 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/28/2012EP2526084A1 Salicylate fatty acid derivatives
11/28/2012EP2525791A2 Special composition for the use thereof as a drug
11/28/2012CN1889965B Use of biocompatible polymers for the preparation of a composition or a medical device
11/28/2012CN102803285A Pharmaceutical composition comprising a steroidal[3,2-c]pyrazole derivative and a second pharmaceutically active compound
11/28/2012CN102803265A Pyrrolopyrazine kinase inhibitors
11/28/2012CN102803263A Purine compounds used as cb2 agonists
11/28/2012CN102803258A Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/28/2012CN102803248A Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
11/28/2012CN102803245A Novel Indole, Indazole And Benzimidazole Arylamides As P2X3 And/or P2X2/3 Antagonists
11/28/2012CN102803237A Oxazole and thiazole derivatives as alx receptor agonists
11/28/2012CN102803235A Compounds which selectively modulate the CB2 receptor
11/28/2012CN102803210A Azetidinyl diamides as monoacylglycerol lipase inhibitors
11/28/2012CN102803199A Novel acetylsalicylic acid salts
11/28/2012CN102802643A Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone
11/28/2012CN102802632A Pharmaceutical composition comprising a pyrimidineone derivative
11/28/2012CN102796647A Health-care liquor
11/28/2012CN102796165A Arg-Tyr modified aliphatic amine/ alcohol derivatives and preparation method and application thereof
11/28/2012CN102796164A Kyotorphin modified fatty amine/alcohol derivative, and preparation method and application thereof
11/28/2012CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
11/28/2012CN102796160A 17ss-hsd1 and sts inhibitors
11/28/2012CN102796099A Imidazoquinolines as lipid kinase inhibitors
11/28/2012CN102796097A Phenanthroindolizidine alkaloid derivative, and preparation method, medical composition and application thereof
11/28/2012CN102796086A Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
11/28/2012CN102796081A Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/28/2012CN102796075A Benzocycloheptenes derivative as well as preparation method and medical application thereof
11/28/2012CN102796073A Method for preparing (R)-alpha-lipoate and preparation thereof, and application of tablet pharmaceutical composition containing (R)-alpha-lipoate
11/28/2012CN102796046A 2-(4-hydroxyl) phenacyl amino-acid-4, 4, 5, 5-tetramethyl-1, 3-, and preparation method and applications thereof
11/28/2012CN102795991A 2-valeryl-1,5-cyclohexadiene-1-carboxylic acid, and synthetic method and application thereof
11/28/2012CN102793921A Methods for treating tweak-related conditions
11/28/2012CN102793897A Ginger and common monkshood mother root cold-eliminating tablet
11/28/2012CN102793895A Oral traditional Chinese medicament for treating cold-dryness cold
11/28/2012CN102793888A Chinese medicinal composition for treating scapulohumeral periarthritis
11/28/2012CN102793884A Chinese medical plaster for treating dysmenorrhea and preparation method thereof
11/28/2012CN102793878A Gout fast analgesic paste
11/28/2012CN102793876A Pharmaceutical composition for treating fever caused by unknown reason as well as preparation method and application of pharmaceutical composition
11/28/2012CN102793873A Medicinal composition for treating rheumatism and preparation method thereof
11/28/2012CN102793861A Chinese medicinal plaster for treating pain in neck, shoulders, waist and legs
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 1272